PMID- 22421698 OWN - NLM STAT- MEDLINE DCOM- 20120718 LR - 20211021 IS - 1537-4521 (Electronic) IS - 0148-5717 (Print) IS - 0148-5717 (Linking) VI - 39 IP - 4 DP - 2012 Apr TI - Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents. PG - 300-5 LID - 10.1097/OLQ.0b013e318244a90f [doi] AB - BACKGROUND: Several studies have assessed risk factors associated with herpes simplex virus-2 (HSV-2) prevalence in adults; however, few have focused on HSV-2 incidence, particularly in adolescents. The objective of this study was to determine HSV-2 prevalence and incidence and associated risk factors in a HIV-1-positive and at risk HIV-1-negative adolescent population. METHODS: Sera were tested for HSV-2 antibodies in 518 adolescents in the Reaching for Excellence in Adolescent Care and Health cohort at baseline and again at the final follow-up visit. Prevalence at baseline and incidence (per person years) of HSV-2 infection were calculated. Furthermore, among HIV-1-positive individuals, a subgroup analysis was performed to assess risk factors for HSV-2 infection. Conditional logistic regression was used to estimate odds ratios and P values for associations between CD4+ T-cell (CD4+) count, HIV-1 viral load (VL), and HSV-2 acquisition, adjusting for antiretroviral therapy use, other sexually transmitted infections, gender, race, and number of sexual partners. RESULTS: At baseline, 179 (35%) subjects were HSV-2 positive, with an additional 47 (16%) new cases being identified during a median follow-up time of 1.95 years and an incidence rate of 7.35 cases per 100 person years. Several risk factors were associated with HSV-2 prevalence (being female, non-Hispanic, uncertainty of sexual preference, and HIV-1 positive) and incidence (using drugs, alcohol, and number of new sexual partners). Among HIV-1 positives, an increase in CD4+ count by 50 cell/mm(3) (odds ratio, 1.17; 95% CI, 1.04-1.31, P = 0.008) was associated with HSV-2 acquisition. CONCLUSIONS: The high prevalence and incidence of HSV-2 infection among adolescents, compared with the general population at this age group suggests a critical need for screening and preventive programs among this targeted group. FAU - Sudenga, Staci L AU - Sudenga SL AD - Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama 35294-0022, USA. FAU - Kempf, Mirjam-Colette AU - Kempf MC FAU - McGwin, Gerald Jr AU - McGwin G Jr FAU - Wilson, Craig M AU - Wilson CM FAU - Hook, Edward W 3rd AU - Hook EW 3rd FAU - Shrestha, Sadeep AU - Shrestha S LA - eng GR - P30 AI027767/AI/NIAID NIH HHS/United States GR - 5P30 AI27767-20/AI/NIAID NIH HHS/United States GR - R25 CA047888/CA/NCI NIH HHS/United States GR - R25 CA047888-23/CA/NCI NIH HHS/United States GR - U01 HD032830-07/HD/NICHD NIH HHS/United States GR - R25CA47888/CA/NCI NIH HHS/United States GR - P30 AI027767-20/AI/NIAID NIH HHS/United States GR - U01-HD32830/HD/NICHD NIH HHS/United States PT - Journal Article PT - Multicenter Study PT - Research Support, N.I.H., Extramural PL - United States TA - Sex Transm Dis JT - Sexually transmitted diseases JID - 7705941 SB - IM MH - Adolescent MH - CD4 Lymphocyte Count MH - Female MH - HIV Seronegativity MH - HIV Seropositivity/*epidemiology/immunology MH - HIV-1/*isolation & purification MH - Herpes Genitalis/*epidemiology/immunology MH - Herpesvirus 2, Human/*isolation & purification MH - Humans MH - Incidence MH - Male MH - Odds Ratio MH - Prevalence MH - Risk Factors MH - Sexual Behavior/*statistics & numerical data MH - Viral Load PMC - PMC3306602 MID - NIHMS347308 EDAT- 2012/03/17 06:00 MHDA- 2012/07/19 06:00 PMCR- 2013/04/01 CRDT- 2012/03/17 06:00 PHST- 2012/03/17 06:00 [entrez] PHST- 2012/03/17 06:00 [pubmed] PHST- 2012/07/19 06:00 [medline] PHST- 2013/04/01 00:00 [pmc-release] AID - 00007435-201204000-00011 [pii] AID - 10.1097/OLQ.0b013e318244a90f [doi] PST - ppublish SO - Sex Transm Dis. 2012 Apr;39(4):300-5. doi: 10.1097/OLQ.0b013e318244a90f.